Yau, Peter Chung Hong 丘忠航

Duncan Chui Tak Keung declared bankrupt
HK Court of First Instance, 17-Nov-2022
Imagi (0585) buys 51% of Supreme China Securities Ltd for HK$27m
Company announcement, 28-Oct-2021
The vendor, which retains 49% of the target, is 50% owned by Terence Hui Wai Yung (who is or was brother-in-law of Peter Yau Chung Hong, according to a 2012 MMT report), 33% by Hang Tai Yue (8081), and 17% by Ms Chan Chiu Mui. Hang Tai Yue, a member of the 2017 "Enigma Network", has not previously disclosed its holding in the vendor. Imagi is a member of what we call the "Chung Nam Network", so the two networks overlap.
Duncan Chui Tak Keung v MMT & Financial Secretary
HK Court of Appeal, 29-May-2013
MMT submits reports on dealings in Sino Katalytics (now Capital VC, 2324) shares
HK Government, 17-Aug-2012
Final MMT report on Sino Katalytics (now Capital VC, 2324)
Market Misconduct Tribunal, 16-Aug-2012
Duncan Chui Tak Keung & Peter Yau Chung Hong found culpable of false trading, price-rigging & market manipulation
Market Misconduct Tribunal, 9-Jul-2012
SFC sanctions Capital VC and Peter Yau Chung HongOur article of 14-Aug-2011
SFC, 22-May-2012
This case was triggered by Webb-site's article of 14-Aug-2011, when we pointed out that an offer should have been made for Longlife (8037). We regard the 18-month "Cold Shoulder Order" as light in duration. The statement says nothing about the fact that Mr Yau and Longlife combined held more than 30% of Capital VC (2324). Meanwhile, Mr Yau is involved in a separate case with the Market Misconduct Tribunal where a ruling is awaited.
Radford (0901): Market Misconduct Tribunal enquiry against INED
Company announcement, 25-Aug-2011
This is something that Webb-site pointed out on 14-Aug-2011. Radford has now granted Mr Yau "administrative leave of absence" until the outcome of the proceedings is known.
Freeman (0279): Market Misconduct Tribunal enquiry against INED
Company announcement, 24-Aug-2011
This is something that Webb-site pointed out on 14-Aug-2011. Freeman has now granted Mr Yau "administrative leave of absence" until the outcome of the proceedings is known.
Capital VC (2324): Market Misconduct Tribunal enquiry against 2 EDs
Company announcement, 19-Aug-2011
The company gets around to announcing something that Webb-site pointed out on 14-Aug-2011.
Longlife (8037) resumes trading
Company announcement, 18-Aug-2011
The company fails to mention that it owned about 8.41% of Capital VC (at last filing) or explain why it bought those shares. The announcement is signed by Cheung Hung, Chairman of Longlife. As we noted in our article, he is a former NED of Capital VC.
Capital VC (2324) combined stake in Longlife (8037) with Mr Yau exceeded 30%
Company announcement, 17-Aug-2011
This follows our article of 14-Aug-2011. We alerted the SFC on 11-Aug-2011. CVC says that from 10-Jun-2011 to 28-Jul-2011, it and Mr Yau had a combined stake over 30% in Longlife. CVC will consult the SFC for a ruling or waiver, but defiantly says "irrespective of the result", it will not make a general offer and Mr Yau won't either. SFC urges CVC and Mr Yau to comply with the Takeover Code or face disciplinary action in respect of any breach. Watch this space.
Capital VC (2324) and Longlife (8037)
Our analysis shows that a general offer may have been triggered for Longlife and possibly for Capital VC too. We look at the close relationship between the two and the people involved. We also ask how a person could continue to act as director of a valuer, issuing valuation opinions for numerous listed companies, without disclosing that he was bankrupt at the time. (14-Aug-2011)
Referal to MMT of Duncan Chui Tak Keung and Peter Yau Chung Hong
Market Misconduct Tribunal, 12-Apr-2011
To determine whether they manipulated the stock of Sino Katalytics (now Capital VC, 2324) ahead of a placing in Jan-2009. Both are directors of the company.
China Northern Enterprises Investment Fund Ltd (2324) and Peter Yau Chung Hong prosecuted
SFC, 3-Nov-2005

Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top